Last updated on December 2018

Study of Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled Asthma


Brief description of study

A randomized, multicenter, double-blind, placebo- controlled parallel-group study to determine the efficacy and safety of QAW039, compared with placebo, when added to standard-of-care (SoC) asthma therapy in adult and adolescent ( 12 years) patients with uncontrolled asthma with respect to change from baseline in forced expiratory volume in 1 second (FEV1) at the end of 12 weeks of treatment.

Clinical Study Identifier: NCT03226392

Find a site near you

Start Over

Novartis Investigative Site

Andalusia, AL United States
  Connect »

Novartis Investigative Site

Birmingham, AL United States
  Connect »

Novartis Investigative Site

Los Angeles, CA United States
  Connect »

Novartis Investigative Site

Newport Beach, CA United States
  Connect »

Novartis Investigative Site

Rolling Hills Estates, CA United States
  Connect »

Novartis Investigative Site

San Diego, CA United States
  Connect »

Novartis Investigative Site

San Jose, CA United States
  Connect »

Novartis Investigative Site

Stockton, CA United States
  Connect »

Novartis Investigative Site

Colorado Springs, CO United States
  Connect »

Novartis Investigative Site

Miami Gardens, FL United States
  Connect »

Novartis Investigative Site

Tallahassee, FL United States
  Connect »

Novartis Investigative Site

Winter Park, FL United States
  Connect »

Novartis Investigative Site

Paducah, KY United States
  Connect »

Novartis Investigative Site

Baltimore, MD United States
  Connect »

Novartis Investigative Site

Columbia, MD United States
  Connect »

Novartis Investigative Site

North Dartmouth, MA United States
  Connect »

Novartis Investigative Site

Ann Arbor, MI United States
  Connect »

Novartis Investigative Site

Kalamazoo, MI United States
  Connect »

Novartis Investigative Site

Minneapolis, MN United States
  Connect »

Novartis Investigative Site

Saint Louis, MO United States
  Connect »

Novartis Investigative Site

Warrensburg, MO United States
  Connect »

Novartis Investigative Site

Brooklyn, NY United States
  Connect »

Novartis Investigative Site

Raleigh, NC United States
  Connect »

Novartis Investigative Site

Cincinnati, OH United States
  Connect »

Novartis Investigative Site

Columbus, OH United States
  Connect »

Novartis Investigative Site

Mayfield Heights, OH United States
  Connect »

Novartis Investigative Site

Altoona, PA United States
  Connect »

Novartis Investigative Site

Pittsburgh, PA United States
  Connect »

Novartis Investigative Site

Mount Pleasant, SC United States
  Connect »

Novartis Investigative Site

New Braunfels, TX United States
  Connect »

Novartis Investigative Site

Newport News, VA United States
  Connect »

Novartis Investigative Site

Spokane, WA United States
  Connect »

Novartis Investigative Site

Anyang-si, Korea, Republic of
  Connect »

Novartis Investigative Site

Bucheon-Si, Korea, Republic of
  Connect »

Novartis Investigative Site

Hwaseong-si, Korea, Republic of
  Connect »

Novartis Investigative Site

Suwon, Korea, Republic of
  Connect »

Novartis Investigative Site

Seoul, Korea, Republic of
  Connect »

Novartis Investigative Site

Incheon, Korea, Republic of
  Connect »

Novartis Investigative Site

Ryazan, Russian Federation
  Connect »

Novartis Investigative Site

Saint-Petersburg, Russian Federation
  Connect »

Novartis Investigative Site

Yaroslavl, Russian Federation
  Connect »

Novartis Investigative Site

Yekaterinburg, Russian Federation
  Connect »

Novartis Investigative Site

Rochester, MN United States
  Connect »

Novartis Investigative Site

Barnaul, Russian Federation
  Connect »

Novartis Investigative Site

Smolensk, Russian Federation
  Connect »

Novartis Investigative Site

Sao Bernardo do Campo, Brazil
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.